Swiss biotech investor Xlife Sciences AG said on Wednesday its portfolio company Veraxa Biotech AG would list on U.S.

State of Flux,' Seska remains one of Star Trek: Voyager's most interesting villains. Voyager and Deep Space Nine draw many ...

Voyager Therapeutics Inc . (NASDAQ:VYGR) stock has reached a 52-week low, touching down at $4.12. According to InvestingPro analysis, the stock's RSI indicates oversold territory, while the ...

Voyager Therapeutics VYGR during the recent three months, expressing a mix of bullish and bearish perspectives. The table below provides a concise overview of recent ratings by analysts, offering ...

The latest price target for Voyager Therapeutics (NASDAQ ... set a price target for $30.00 expecting VYGR to rise to within 12 months (a possible 858.47% upside). 20 analyst firms have reported ...

H.C. Wainwright argues that Voyager’s presentations at the Alzheimer’s & Parkinson’s Disease meeting April 1-5 “further strengthen the ...